(VIANEWS) - The Innrs Artificial Intelligence algorithm has been making predictions about the next day stock price and guessing some of them correctly.
We, at Via News, will follow this AI algorithm and publish the results every week day.
Yesterday's AI prediction for today would produce a ROI of 0.4% if an investor was to invest following yesterday's Innrs AI suggestion.
See the data in the table below.
| Financial Asset | Accuracy | Previous Close | Prediction | Close Price | ROI |
|---|---|---|---|---|---|
| Yamana Gold (AUY) | 83.13% | $5.48 | $5.51 | $5.62 | 2.55% ✅ |
| Regeneron Pharmaceuticals (REGN) | 83.91% | $746.2 | $766.39 | $764.27 | 2.42% ✅ |
| Kodak (KODK) | 90.04% | $3.97 | $3.66 | $3.89 | 2.02% ✅ |
| Incyte Corporation (INCY) | 88.83% | $82.57 | $84.05 | $84.03 | 1.77% ✅ |
| Air Products and Chemicals (APD) | 83.95% | $312.51 | $314.32 | $315.58 | 0.98% ✅ |
| Genmab (GMAB) | 83.74% | $45.4 | $46.34 | $45.72 | 0.7% ✅ |
| Datadog (DDOG) | 88.26% | $68.69 | $64.5 | $68.28 | 0.6% ✅ |
| Coca-Cola (KO) | 83.67% | $63.44 | $64.9 | $63.54 | 0.16% ✅ |
| Amicus Therapeutics (FOLD) | 83.73% | $12.23 | $12.27 | $12.18 | -0.41% |
| Exelon (EXC) | 88.31% | $42.81 | $44.03 | $42.31 | -1.17% |
| Ross Stores (ROST) | 83.35% | $116.75 | $121.85 | $115.36 | -1.19% |
| VALE (VALE) | 83.45% | $16.78 | $17.13 | $16.17 | -3.64% |
1. Yamana Gold (AUY)
Shares of Yamana Gold fell 0% in from $0 to $0.00 at 21:29 EST on Wednesday, following the last session's upward trend. NYSE is sliding 0.11% to $15,311.79, after three consecutive sessions in a row of losses.
Yamana Gold Inc., together with its subsidiaries, operates as a precious metal producer.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.83%.Growth Estimates Quarters
For the current quarter, the company expects to grow by a net 50% and 44.4% respectively.More news about Yamana Gold.
2. Regeneron Pharmaceuticals (REGN)
Shares of Regeneron Pharmaceuticals dropped 0% in from $0 to $0.00 at 21:29 EST on Wednesday, following the last session's upward trend. NASDAQ is falling 0.51% to $10,958.55, after four sequential sessions in a row of losses.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 31.76%.Moving Average
Regeneron Pharmaceuticals is worth less than its moving average over 50 days of $733.09, and its moving average over 200 days of $662.63.Revenue Growth
Year-on-year quarterly revenue growth declined by 44.4%, now sitting on 14.23B for the twelve trailing months.
Sales Growth
Regeneron Pharmaceuticals's sales growth is 2.3% for the present quarter and negative 36.4% for the next.
More news about Regeneron Pharmaceuticals.
3. Kodak (KODK)
Shares of Kodak fell 0% in from $0 to $0.00 at 21:29 EST on Wednesday, after five sequential sessions in a row of losses. NYSE is falling 0.11% to $15,311.79, after three sequential sessions in a row of losses.
Eastman Kodak Company supplies hardware, software and consumables to its customers worldwide in the areas of commercial printing, packaging, publishing and manufacturing.
For the 12 trailing months, the company's return-on-equity, which is an indicator of the business' profitability relative to shareholders' equity, was 2.35%.Revenue Growth
Year-on-year quarterly revenue growth grew by 9.4%, now sitting on 1.18B for the twelve trailing months.
Annual Top and Bottom Value
Kodak stock was valued at $0.00 as of 21:29 EST at the low 52-week low at $3.46
More news about Kodak.
4. Incyte Corporation (INCY)
Shares of Incyte Corporation slid 0% in from $0 to $0.00 at 21:29 EST on Wednesday, following the last session's upward trend. NASDAQ is dropping 0.51% to $10,958.55, after four successive sessions in a row of losses.
Incyte Corporation is a biopharmaceutical firm that focuses on developing, commercializing, and distributing proprietary therapeutics throughout the United States.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability of a company relative to shareholders' equity, was 23.76%.Moving Average
Incyte Corporation's worth is below its 50-day moving average of $73.36 and below its 200-day moving average of $74.48.Revenue growth
The year-on-year revenue growth was 1.3%. It now stands at 3.33B in the 12 trailing months.
More news about Incyte Corporation.
5. Air Products and Chemicals (APD)
Shares of Air Products and Chemicals jumped by a staggering 11.25% in from $283.72 to $315.64 at 21:29 EST on Wednesday, following the last session's upward trend. NYSE is falling 0.11% to $15,311.79, after three successive sessions in a row of losses.
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and services worldwide.
PE Ratio
Air Products and Chemicals' trailing 12-month price-to-earnings ratio is 37.08. The purchaser of the shares is therefore investing $37.08 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 16.17%.Revenue Growth
Year-on-year quarterly revenue growth grew by 22.4%, now sitting on 11.97B for the twelve trailing months.
Moving Average
Air Products and Chemicals's worth is way above its 50-day moving average of $263.31 and way higher than its 200-day moving average of $248.58.Volume
Today's last reported volume for Air Products and Chemicals is 904149 which is 15.43% below its average volume of 1069220.
Dividend Yield
Morningstar, Inc. claims that the next dividend payment will be on Sep 29, 2022. The forward dividend rate and yield are both 6.48 and 2.6% respectively.
More news about Air Products and Chemicals.
6. Genmab (GMAB)
Shares of Genmab slid 0% in from $0 to $0.00 at 21:29 EST on Wednesday, following the last session's upward trend. NASDAQ is falling 0.51% to $10,958.55, after four consecutive sessions in a row of losses.
Genmab A/S is a Danish company that develops and markets antibody therapies for cancer treatment.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 17.71%.More news about Genmab.
7. Datadog (DDOG)
Shares of Datadog fell 0% in from $0 to $0.00 at 21:29 EST on Wednesday, after four sequential sessions in a row of losses. NASDAQ is falling 0.51% to $10,958.55, after four sequential sessions in a row of losses.
Datadog, Inc. provides monitoring and analytics platform for developers, information technology operations teams, and business users in the cloud in North America and internationally.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.62%.Sales Growth
Datadog's sales growth is 53.2% for the ongoing quarter and 37% for the next.
Volatility
Datadog's last week, last month's, and last quarter's current intraday variation average was a negative 3.40%, a negative 0.11%, and a positive 3.38%.
Datadog's highest amplitude of average volatility was 3.40% (last week), 4.50% (last month), and 3.38% (last quarter).
More news about Datadog.
8. Coca-Cola (KO)
Shares of Coca-Cola dropped 0% in from $0 to $0.00 at 21:29 EST on Wednesday, after two consecutive sessions in a row of gains. NYSE is sliding 0.11% to $15,311.79, after three successive sessions in a row of losses.
Coca-Cola Company is a global beverage manufacturer, marketer, and seller of non-alcoholic beverages.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 41.03%.More news about Coca-Cola.
9. Amicus Therapeutics (FOLD)
Shares of Amicus Therapeutics dropped 0% in from $0 to $0.00 at 21:29 EST on Wednesday, after three sequential sessions in a row of losses. NASDAQ is sliding 0.51% to $10,958.55, after four sequential sessions in a row of losses.
Amicus Therapeutics, Inc. is a biotechnology company that focuses on the discovery, development, and delivery of medicines for rare conditions.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a company, was negative at -145.09%.Growth Estimates Quarters
The company's growth estimates for the current quarter and the next is 55.2% and 63.3%, respectively.More news about Amicus Therapeutics.
10. Exelon (EXC)
Shares of Exelon dropped 0% in from $0 to $0.00 at 21:29 EST on Wednesday, following the last session's downward trend. NASDAQ is dropping 0.51% to $10,958.55, after four successive sessions in a row of losses.
Exelon Corporation, a utility services holding company, engages in the energy generation, delivery, and marketing businesses in the United States and Canada.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.62%.Sales Growth
Exelon sales growth was negative 56.6% in the most recent quarter, and 3.4% the following.
Moving Average
Exelon's value is below its moving average 50 days of $38.39, and its moving average 200 days of $43.68.More news about Exelon.
11. Ross Stores (ROST)
Shares of Ross Stores fell 0% in from $0 to $0.00 at 21:29 EST on Wednesday, after three sequential sessions in a row of losses. NASDAQ is dropping 0.51% to $10,958.55, after four consecutive sessions in a row of losses.
Ross Stores, Inc., along with its affiliates, operate off-price home fashion and apparel stores under the Ross Dress for Less, dd’s DISCOUNTS brands.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 36.73%.Revenue Growth
Year-on-year quarterly revenue growth declined by 4.6%, now sitting on 18.51B for the twelve trailing months.
More news about Ross Stores.
12. VALE (VALE)
Shares of VALE jumped by a staggering 12.53% in from $14.44 to $16.25 at 21:29 EST on Wednesday, after two successive sessions in a row of losses. NYSE is falling 0.11% to $15,311.79, after three consecutive sessions in a row of losses.
Vale S.A., together with its subsidiaries, produces and sells iron ore and iron ore pellets for use as raw materials in steelmaking in Brazil and internationally.
Earnings per Share
VALE's trailing 12 month EPS is $2.02.
PE Ratio
VALE's trailing 12 months earnings to price ratio is 8.05. The purchaser of the shares is paying $8.05 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 50.59%.More news about VALE.